SK15492003A3 - Protinádorové prípravky tioxantenónu - Google Patents
Protinádorové prípravky tioxantenónu Download PDFInfo
- Publication number
- SK15492003A3 SK15492003A3 SK1549-2003A SK15492003A SK15492003A3 SK 15492003 A3 SK15492003 A3 SK 15492003A3 SK 15492003 A SK15492003 A SK 15492003A SK 15492003 A3 SK15492003 A3 SK 15492003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pharmaceutically acceptable
- amino
- diethylamino
- formamide
- methoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0115893.0A GB0115893D0 (en) | 2001-06-28 | 2001-06-28 | Formulations |
| PCT/GB2002/003012 WO2003002202A1 (en) | 2001-06-28 | 2002-06-28 | Antitumoral formulations of thioxanthenone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK15492003A3 true SK15492003A3 (sk) | 2004-06-08 |
Family
ID=9917582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1549-2003A SK15492003A3 (sk) | 2001-06-28 | 2002-06-28 | Protinádorové prípravky tioxantenónu |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050176619A1 (es) |
| EP (1) | EP1406699A1 (es) |
| JP (1) | JP2004536099A (es) |
| KR (1) | KR20040030709A (es) |
| CN (1) | CN1520325A (es) |
| AR (1) | AR034621A1 (es) |
| BG (1) | BG108459A (es) |
| BR (1) | BR0210671A (es) |
| CA (1) | CA2451195A1 (es) |
| CZ (1) | CZ20033434A3 (es) |
| EE (1) | EE200400041A (es) |
| GB (1) | GB0115893D0 (es) |
| HR (1) | HRP20031048A2 (es) |
| HU (1) | HUP0402039A2 (es) |
| IL (1) | IL159206A0 (es) |
| IS (1) | IS7070A (es) |
| MX (1) | MXPA03012064A (es) |
| NO (1) | NO20035668D0 (es) |
| PL (1) | PL367636A1 (es) |
| RU (1) | RU2003136086A (es) |
| SK (1) | SK15492003A3 (es) |
| WO (1) | WO2003002202A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5165387B2 (ja) * | 2005-02-11 | 2013-03-21 | イムノゲン インコーポレーティッド | 安定な薬物複合体を調製するための方法 |
| CA2892010A1 (en) * | 2012-11-20 | 2014-05-30 | Vita Naturale, Llc | Compositions and methods for their dermatological use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5346917A (en) * | 1991-06-10 | 1994-09-13 | Sterling Winthrop Inc. | Thioxanthenone antitumor agents |
| US5665760A (en) * | 1995-09-18 | 1997-09-09 | Sanofi Winthrop, Inc. | Lyophilized thioxanthenone antitumor agents |
| US20030022920A1 (en) * | 2001-06-19 | 2003-01-30 | Christoph Ullmer | 1-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonist |
-
2001
- 2001-06-28 GB GBGB0115893.0A patent/GB0115893D0/en not_active Ceased
-
2002
- 2002-06-24 AR ARP020102369A patent/AR034621A1/es not_active Application Discontinuation
- 2002-06-28 US US10/480,692 patent/US20050176619A1/en not_active Abandoned
- 2002-06-28 MX MXPA03012064A patent/MXPA03012064A/es not_active Application Discontinuation
- 2002-06-28 PL PL02367636A patent/PL367636A1/xx not_active Application Discontinuation
- 2002-06-28 EP EP02748985A patent/EP1406699A1/en not_active Withdrawn
- 2002-06-28 CZ CZ20033434A patent/CZ20033434A3/cs unknown
- 2002-06-28 KR KR10-2003-7016976A patent/KR20040030709A/ko not_active Application Discontinuation
- 2002-06-28 BR BR0210671-0A patent/BR0210671A/pt not_active IP Right Cessation
- 2002-06-28 HU HU0402039A patent/HUP0402039A2/hu unknown
- 2002-06-28 WO PCT/GB2002/003012 patent/WO2003002202A1/en not_active Application Discontinuation
- 2002-06-28 EE EEP200400041A patent/EE200400041A/xx unknown
- 2002-06-28 SK SK1549-2003A patent/SK15492003A3/sk unknown
- 2002-06-28 RU RU2003136086/15A patent/RU2003136086A/ru not_active Application Discontinuation
- 2002-06-28 CA CA002451195A patent/CA2451195A1/en not_active Abandoned
- 2002-06-28 CN CNA028127552A patent/CN1520325A/zh active Pending
- 2002-06-28 JP JP2003508438A patent/JP2004536099A/ja active Pending
- 2002-06-28 IL IL15920602A patent/IL159206A0/xx unknown
-
2003
- 2003-12-11 IS IS7070A patent/IS7070A/is unknown
- 2003-12-16 BG BG108459A patent/BG108459A/xx unknown
- 2003-12-17 HR HR20031048A patent/HRP20031048A2/xx not_active Application Discontinuation
- 2003-12-18 NO NO20035668A patent/NO20035668D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003002202A1 (en) | 2003-01-09 |
| AR034621A1 (es) | 2004-03-03 |
| PL367636A1 (en) | 2005-03-07 |
| RU2003136086A (ru) | 2005-05-27 |
| BG108459A (en) | 2005-02-28 |
| EP1406699A1 (en) | 2004-04-14 |
| CN1520325A (zh) | 2004-08-11 |
| IS7070A (is) | 2003-12-11 |
| CA2451195A1 (en) | 2003-01-09 |
| US20050176619A1 (en) | 2005-08-11 |
| EE200400041A (et) | 2004-04-15 |
| MXPA03012064A (es) | 2004-03-26 |
| GB0115893D0 (en) | 2001-08-22 |
| HRP20031048A2 (en) | 2004-04-30 |
| NO20035668D0 (no) | 2003-12-18 |
| BR0210671A (pt) | 2004-10-13 |
| CZ20033434A3 (cs) | 2004-08-18 |
| IL159206A0 (en) | 2004-06-01 |
| KR20040030709A (ko) | 2004-04-09 |
| HUP0402039A2 (hu) | 2005-01-28 |
| JP2004536099A (ja) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100613136B1 (ko) | 미셀-형성 계면활성제를 함유하는 에키노칸딘 제약학적조제물 | |
| CN108635367B (zh) | 地西他滨衍生物制剂 | |
| CZ20003089A3 (cs) | Stabilní roztok oxiplatiny, způsob jeho přípravy, farmaceutický prostředek a použití | |
| TW201039865A (en) | Lyophilized preparations of proteasome inhibitors | |
| KR20110010753A (ko) | 트레프로스티닐 일수화물 | |
| US20090036462A1 (en) | Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones | |
| US20220257607A1 (en) | Formulations and dosages for administering a compound that inhibits mcl1 protein | |
| KR20010112302A (ko) | 제약학적 경구용 ｅｃｂ 조제물 및 조성물의 제조 방법 | |
| Vora et al. | Bortezomib–first therapeutic proteasome inhibitor for cancer therapy: a review of patent literature | |
| WO2023227052A1 (zh) | 双环衍生物parp抑制剂及其用途 | |
| NZ224497A (en) | Pharmaceutical composition comprising flunarizine | |
| CN111116462A (zh) | 一种瑞戈非尼和汉黄芩素共晶体及其应用 | |
| EP3890703B1 (en) | Novel pharmaceutical formulation comprising a sting modulator | |
| JP2013151574A (ja) | チューブリンインヒビターであるインジブリン（Ｉｎｄｉｂｕｌｉｎ）の改良された薬物動態学を有する、経口投与のための薬剤組成物、及びその製造法 | |
| KR20040106422A (ko) | 간암 및 다른 암 질병 치료용 에포틸론 유도체 | |
| SK15492003A3 (sk) | Protinádorové prípravky tioxantenónu | |
| JP2005503323A5 (es) | ||
| JP2011529930A (ja) | 注射可能タキサン医薬品組成物 | |
| KR20220143063A (ko) | 암의 치료에 유용한 TGFβ 길항제 전구약물을 함유하는 제제화된 및/또는 공동-제제화된 리포솜 조성물 및 그의 방법 | |
| JPS6310685B2 (es) | ||
| AU2002319400A1 (en) | Antitumoral formulations of thioxanthenone | |
| US7582762B2 (en) | Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline | |
| JP3990728B2 (ja) | Ｎ−［４−オキソ−２−（１ｈ−テトラゾール−５−イル）−４ｈ−１−ベンゾピラン−８−イル］−４−（４−フェニルブトキシ）ベンズアミドの塩 | |
| KR20090038902A (ko) | 에포틸론 ｂ의 결정 형태 및 제약 조성물에서의 용도 | |
| EP4288417A1 (en) | Substituted pyrazolyl compounds as malt-1 inhibitors |